Phase Genomics, Inc. — Form D
Phase Genomics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-21. The offering totals $6.6M, of which $4.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-21
- Form: D
- Accession: 0001722760-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $4.8M
- Remaining: $1.8M
- Investors: 13
- Date of first sale: 2023-03-14
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-476536
Issuer
- Name: Phase Genomics, Inc.
- CIK: 0001722760
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1617 8th Ave. North, SEATTLE, WA, 98109
- Phone: 206-384-6228
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ivan Liachko | Director | Seattle, WA |
| Ivan Liachko | Executive Officer | Seattle, WA |
| Shawn Sullivan | Executive Officer | Seattle, WA |
| Kayla Young | Executive Officer | Seattle, WA |
| Ivan Liachko | Promoter | Seattle, WA |
| Shawn Sullivan | Promoter | Seattle, WA |
Other filings by this issuer (1)
More